Sarah Fishman, M.D. PH.D
Opted out of Medicare from July 2024 to July 2028. Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D. PH.D) in New York, New York, trained at Icahn School of Medicine at Mount Sinai (class of 2003). Their prescriptions cost Medicare Part D more than their services did: $1,013,707 for 1,404 claims, against $19,570 paid for services in 2024. Abbott Laboratories was the largest of 27 companies reporting payments in 2025, $8,807 in all, mostly compensation for serving as faculty or as a speaker for a me.
Overview
| NPI | 1568705838 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. PH.D |
| Sole proprietor | Yes |
| NPI issued | Apr 4, 2013 |
| Last updated in NPPES | Sep 6, 2018 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | 276940 | NY |
| Internal Medicine | 207R00000X | 276940 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Jul 1, 2024 – Jul 1, 2028 |
| Can order and refer | Yes |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 119 |
|---|---|
| Services billed | 364 across 8 procedure codes |
| Paid by Medicare | $19,570 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,404 · 2,802 30-day fills |
|---|---|
| Patients | 139 |
| Total drug cost | $1,013,707 |
| Generic share | 37% of claims |
Education and affiliations
| Medical school | Icahn School of Medicine at Mount Sinai |
|---|---|
| Graduation year | 2003 |
| Medicare specialty | Endocrinology |
Industry payments (Open Payments)
- 2025$8,807 · 131 payments from 27 companies
- 2024$7,278 · 130 payments from 20 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Abbott Laboratories | $6,142 | 8 |
| Novo Nordisk Inc | $492.46 | 21 |
| Amgen Inc. | $281.00 | 13 |
| Lilly USA, LLC | $255.11 | 10 |
| Madrigal Pharmaceuticals | $224.86 | 10 |
What the 2025 payments were for
- Compensation for serving as faculty or as a speaker for a medical education program$5,938 · 7 payments
- Food and Beverage$2,870 · 124 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other endocrinologists in New York
- 1003042169
- 1003989211
- 1013078732
- 1013085596
- 1013189646
- 1013476969
- 1023195401
- 1053335356
- 1063654994
- 1063863066
- 1073627063
- 1104277219
All 345 endocrinologists in New York · All endocrinologists in New York